Rigetti Computing secures a significant order to deliver a 108-qubit quantum system to India's Centre for Development of Advanced Computing, marking a key commercial milestone and international expansion for the company amidst volatile stock performance.
CNBC's Jim Cramer reaffirmed his bullish stance on Rio Tinto, highlighting the mining giant's role as a strategic hedge against geopolitical and economic volatility during the show's Lightning Round.
Kalmar Oyj embarks on a strategic, long-term IT transformation with Tata Consultancy Services, building an AI-powered digital core to streamline operations, enhance equipment reliability, and solidify its service-led business model in the competitive port equipment sector.
Spanish healthtech startup Biorce has closed a substantial Series A round, backed by prominent venture capital and angel investors, to scale its AI-driven clinical trial solution, Aika, internationally amid a tightening regulatory landscape.
The latest release of court documents from the Jeffrey Epstein case has sent shockwaves through international corridors of power, revealing communications between the convicted sex offender and high-profile figures in India, Australia, the UK, Slovakia, and Norway, prompting resignations and fierce political denials.
Taiwan Semiconductor Manufacturing Company (TSMC), commanding over 70% of the advanced chip foundry market, is accelerating its U.S. manufacturing footprint amid shifting trade policies and sustained explosive financial growth, solidifying its indispensable role.
A KKR-led group is finalizing a deal to acquire Singapore-based data centre operator STT GDC, a move that underscores the intense global competition for digital infrastructure assets as AI-driven demand surges across Asia.
From Mussolini's Rome-Berlin Axis to Bush's 'Axis of Evil,' the term has evolved into a potent geopolitical label. Its revival to describe groupings like the 'Axis of Upheaval' reveals how language frames modern conflicts and defines the boundaries of legitimacy in international politics.
IDEXX Laboratories reports robust fourth-quarter and full-year 2025 results, with double-digit revenue growth fueled by record instrument placements and strategic innovations like InVue DX and CancerDx. The company provides a confident outlook for 2026, targeting continued organic growth despite sector headwinds.
Chinese biotech firm Arctic Vision moves to create an integrated ophthalmology powerhouse by acquiring MDCO Technology's device business, combining drug and device expertise to address unmet needs in eye care.
IPSASB unveils the world's first dedicated climate reporting standard for governments and public bodies, mandating disclosures from 2028 to illuminate financial risks and opportunities.
The luxury retailer is moving to terminate its 'Saks on Amazon' partnership as part of its Chapter 11 proceedings, aiming to refocus on core luxury operations while navigating disputes over financial commitments and brand concerns.
Amid a market environment of stable rates and mixed sentiment, we highlight three companies—spanning biotech, gaming, and tech hardware—whose current share prices appear significantly below their estimated intrinsic value based on cash flow projections.
Amidst a cautious market climate, companies with substantial insider ownership often signal strong internal conviction. We examine three such firms—spanning South Korean tourism, Chinese sensors, and Taiwanese biopharma—where executives and directors have significant skin in the game.
Amidst market volatility and economic crosscurrents, income-focused investors are revisiting dividend stocks for potential stability and yield. We examine three Japanese companies offering yields from 3.3% to 6.3%, analyzing their sustainability and strategic outlook.
The Austrian government has granted a two-year renewal for the Wolfsberg lithium mining license, with a final decision on production expected by end-2026 as lithium prices rebound strongly.
Terns Pharmaceuticals has restructured a key licensing deal with China's Hansoh, gaining exclusive worldwide rights for its TERN-701 oncology drug outside Greater China. The strategic move, coupled with a recent analyst price target surge, signals the company's aggressive push into international markets.
The UK's economic recovery faces a significant drag from recently implemented fiscal tightening, with growth forecasts remaining subdued for the coming year, according to a leading economic forecaster.
Russia's former president Dmitry Medvedev cautions that the potential lapse of the last major U.S.-Russia nuclear arms treaty without a successor could plunge the world into an unprecedented era of strategic instability unseen since the Cold War.
As voters from Japan to Brazil head to the polls in a packed electoral calendar, investors brace for potential market volatility. The outcomes could redefine fiscal policies, international alliances, and economic trajectories in a world already navigating U.S. monetary uncertainty and geopolitical strife.
